Maxitrol

Neomycin sulfate, Polymyxin B sulfate and Dexamethasone, the active ingredients in Maxitrol, are a combination antibiotic and corticosteroid presented as an ophthalmic preparation for ocular use. It treats bacterial eye infections and associated inflammation in patients requiring topical therapy.

GNH USA supplies Maxitrol as a licensed, GDP‑compliant international pharmaceutical supplier, delivering the product to hospitals, pharmacies, transplant centres and clinics worldwide, with established quality‑assured logistics and regulatory support. The company ensures consistent availability across EU and other markets through rigorous quality control and reliable supply chain management.

Maxitrol, a combination antibiotic and corticosteroid eye drop, is used to manage bacterial ocular infections and inflammatory conditions.

- Bacterial conjunctivitis: reduces bacterial load and alleviates associated redness and discharge. - Keratitis: treats infection of the cornea while controlling inflammation. - Post‑operative ocular inflammation: minimizes swelling and pain after eye surgery. - Blepharitis: clears bacterial involvement and reduces eyelid inflammation.

Adverse ocular reactions may occur with Maxitrol use.

Common Side Effects: - Burning or stinging sensation - Transient blurred vision - Mild itching of the eye

Serious or Rare Side Effects: - Increased intra‑ocular pressure - Secondary bacterial or fungal infection - Severe allergic reaction (angioedema or anaphylaxis)

Before using Maxitrol, consider the following precautions.

- Avoid use in patients with known hypersensitivity to any component: discontinue immediately if a reaction occurs. - Monitor intra‑ocular pressure during prolonged therapy: schedule regular ophthalmic examinations. - Do not use on viral or fungal eye infections: may worsen the condition. - Limit duration as prescribed: prolonged use can increase risk of cataract formation. - Avoid contact lens wear during treatment: remove lenses before instillation. - Store at room temperature (below 25 °C): keep in original container, protect from moisture and light.

Maxitrol may interact with other medicines; review the following.

Major Interactions (Avoid): - Concurrent use of other topical corticosteroids: may cause additive systemic absorption and increased intra‑ocular pressure. - Systemic aminoglycoside therapy: potential additive nephrotoxicity and ototoxicity. - Live vaccines: immunosuppression from the corticosteroid may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: may increase risk of corneal thinning. - Anticholinergic eye drops: possible reduced efficacy of Maxitrol. - Systemic CYP450 inducers: may slightly reduce dexamethasone levels.